The turnover of retail of Western Medicine in China is projected to see a decline from 6.23 hundred million Yuan Renminbi in 2024 to 5.84 in 2028. The year-on-year percentage variation shows a steady decrease of roughly 1.6% annually. Compared to 2023, the turnover stood slightly higher, and this trend projects an average annual decline (CAGR) of approximately 1.6% over the five-year period.

Future trends to watch for:

Potential market consolidation as smaller players may struggle to remain profitable amidst declining sales.
Increased focus on digital health solutions and online retailing which may partially offset the decline in traditional retail channels.
Rising healthcare reforms and policies that could directly impact the pricing and availability of Western medicines.